Northwestern University Feinberg School of Medicine

Department of Medicine

News and Announcements

Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Medicine. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards, and honors.

  • 03.14.2018 - Hematology-Oncology
    The Department congratulates Jayesh Mehta, MD, and Seema Singhal, MD, both professors of medicine in the division of hematology and oncology in the Feinberg School of Medicine, have been jointly appointed as the Chez Family Foundation Professor of Myeloma Research
  • 03.13.2018 - Rheumatology
  • 03.08.2018 - Cardiology

    Northwestern Medicine scientists usher in a new era of genetic research. 

    Featuring Elizabeth McNally, MD, PhD

  • 03.07.2018 - Hematology-Oncology

    Maha Hussain, MD, recently published several papers detailing new findings in metastatic castration-resistant prostate cancer treatment and prostate cancer screening.

  • 03.07.2018 - Hematology-Oncology

    Cancer treatment tailored to each unique individual. This is the potential of precision oncology, and the premise of OncoSET.

  • 03.07.2018 - Cardiology
    Cholesterol-lowering meds can reduce risk of heart disease.  Featuring:  Neil Stone, MD
  • 03.07.2018 - Cardiology
    Dearth of data from non-white groups may reduce conclusive testing.  Featuring:  Elizabeth McNally, MD, PhD
  • 03.07.2018 - Cardiology

    Being obese or overweight may increase morbidity and mortality.

    Featuring:  Sadiya Khan, MD

  • 03.07.2018 - Hematology-Oncology

    Dr. Maha Hussain outlines how results from the PROSPER study might impact the treatment landscape for patients with nonmetastatic (M0) prostate cancer that is no longer responding to hormonal therapy, called castration resistant prostate cancer (CRPC).

  • 03.06.2018
    More than 100 Northwestern employees were on site Saturday from across the health system greeting patients getting acclimated to the new space.
  • 03.05.2018 - Infectious Diseases

    Diverse sexual trends called “sexual sorting” may be driving Chicago’s young adults to some of the highest sexually transmitted infection rates in the country.  Dr. Michael Angarone, assistant professor of Infectious Diseases at Northwestern University’s Feinberg School of Medicine and a physician at Northwestern’s STI clinic, said that Chicago has historically been on the higher end of STI rates in urban areas, and that it is both predictable and surprising that Chicago is still seeing such high rates.

  • 03.03.2018 - Gastroenterology and Hepatology
    "University of Chicago Medicine and Northwestern Memorial Hospital, two of the five adult liver transplant centers in Illinois, recently changed their six-month-sober policies so that select people with acute alcoholic hepatitis — a small subset of people with alcoholic liver disease — can be considered for transplants without undergoing a set period of abstinence."
  • 02.28.2018 - Hematology-Oncology

    Even as a growing number of cancer patients are setting up accounts for online access to medical charts, fewer people are actually logging on to look at their test results, a U.S. study suggests.

    For the study, researchers examined data on 44,590 cancer patients treated between 2007 and 2016, including 19,434 who set up online MyChart accounts to get remote access to their records.

    During this decade, the proportion of patients with MyChart accounts rose from 26 percent to 62 percent, researchers report in JAMA Oncology.

    In recent years, however, the number of people checking their test results online declined, from 61 percent in 2012 to 38 percent by the end of the study.

  • 02.26.2018 - Cardiology
    Featuring:  Mark Ricciardi, MD
  • 02.22.2018 - Hematology-Oncology

    “Exceptional care will never be good enough if we don’t have a cure or impactful treatments for our patients,” says Deputy Director, Maha Hussain, MD. “That’s why my passion is research. Research is what will cure cancer.”

  • 02.21.2018 - Infectious Diseases

    In her Today article from 1/6/18, Linda Carroll reports how it is impossible for the flu shot to give you the flu. If you feel sick after receiving the flu shot, your symptoms were not caused by the flu shot you just received; possible culprits include a virus or a cold, or a previous attack of the flu before you received the flu shot. 

    Michael Ison, MD, and professor in Infectious Diseases at Northwestern University's Feinberg School of Medicine adds that most people receive the flu shot in the fall which is during the same time period that other viruses are often prevalent. People mistaking a virus or cold for the flu misplace blame on an innocent flu shot received.  Additionally, there are side effects from a flu shot, but these only include arm soreness, fatigue, or a headache, not full blown flu.  Last, flu shots take 2-3 weeks to become fully effective, so "if you were exposed to the flu shortly after being vaccinated your body didn't have enough time to marshal its forces against the virus..." Ison explains. 

    There are no known reasons not to get a flu shot.  People with egg allergies have even been cleared to get one. 

  • 02.20.2018 - Allergy-Immunology

    A drug originally designed for chemotherapy successfully suppressed allergic responses to food allergens, according to a Northwestern Medicine study published in the Journal of Allergy and Clinical Immunology.

    The drug, ibrutinib, interrupted the process that causes the body’s cells to react to food allergens such as peanuts or shellfish, showing potential for reducing the severity and risk of allergic reactions, according to lead author Melanie Dispenza, MD, PhD, third-year fellow in the Allergy and Immunology Fellowship Program.

    “This drug is reasonably safe and it effectively blocks allergic responses in cells,” said Bruce Bochner, MD, the Samuel M. Feinberg Professor of Medicine in the Division of Allergy and Immunology, who was senior author of the study.

  • 02.18.2018 - Gastroenterology and Hepatology
    "Listening to your gut is about more than responding to your body when you feel uneasy or need to make a decision."
  • 02.14.2018 - Hematology-Oncology

    Marcus Peter, PhD, the Tom D. Spies Professor of Cancer Metabolism, was the senior author of the study that discovered why Huntington’s disease is toxic to cancer cells, a finding that may lead to new cancer therapies, according to a new study published in the journal EMBO Reports. Patients with Huntington’s disease, a fatal genetic illness that causes the breakdown of nerve cells in the brain, have up to 80 percent less cancer than the general population.

  • 02.12.2018
    Situated on a 160-acre campus with pedestrian and bike paths, the new $399 million Northwestern Medicine Lake Forest Hospital opens today.
  • 02.12.2018 - Rheumatology

    The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health announces five new Core Centers for Clinical Research (CCCR) (P30) awards. The CCCRs provide avenues to advance the methodological sciences that support clinical research within and across the NIAMS' scientific portfolio. The overall goal of the CCCRs is to develop and apply methods, metrics, and outcome measures that address existing and emerging clinical research needs to advance the prevention, diagnosis, and treatment of musculoskeletal, rheumatologic, and skin diseases.


    Based on internal review, along with inputs from an externally convened Centers Evaluation Working Group and a public Request for Information, the NIAMS decided that the traditional Multidisciplinary Clinical Research Centers (i.e., P60), originally established in 2001 to promote clinical, epidemiological, and health-services research, needed to be updated. This new NIAMS CCCR program is in response to that decision. 


    Each CCCR award includes, at minimum, a strong methodologic core and an administrative research core focused on supporting clinical research. The program is intended to be flexible, innovative, and adaptable, and to accommodate and address pressing needs of the NIAMS clinical research community.


    The 2017 CCCR awards are:


    Improving Minority Health in Rheumatic Diseases (IMHRD) — This CCCR, based at the Medical University of South Carolina and led by Gary S. Gilkeson, M.D., will provide research resources to enable and enhance clinical and translational research on two autoimmune connective tissue diseases, scleroderma and lupus, that have a disparate impact on African American women. A major emphasis will be on communicating and collaborating with minority patient groups and communities to encourage input and participation in clinical research and health promotion activities. The work is intended to contribute to the elimination of health disparities for individuals with scleroderma or lupus and to improve the health of those at an increased risk for one of these diseases.


    Indiana Core Center for Clinical Research (ICCCR) in Musculoskeletal Health — The overarching theme of the ICCCR is to better define musculoskeletal diseases that have common pathogenesis and clinical presentations. The team of investigators, led by Sharon M. Moe, M.D., with support from Mike Econs, M.D., Stuart Warden, Ph.D., and Eric Imel, M.D. at Indiana University, and Connie Weaver, Ph.D. at Purdue University, will integrate a network of electronic health records and molecular profiles to identify genetic factors and clinical and biochemical phenotypes. In addition, they aim to standardize physical function measurements and imaging modalities to define the diseases’ functional and morphologic phenotypes. Improving the definition and diagnosis of these musculoskeletal conditions could lead to personalized medicine through health care providers prescribing tailored treatment for each patient.


    VERITY: Value and Evidence in Rheumatology Using Bioinformatics, and Advanced Analytics — The Brigham and Women’s Hospital CCCR, led by Daniel Hal Solomon, M.D., M.P.H., is organized around scientific themes that can be applied to multiple rheumatic and musculoskeletal diseases. Investigators will explore strategies for: including patients in clinical trial design and result interpretation and dissemination; using behavioral economics methods to enhance the benefits of interventions that are known to be effective; extracting information from large, diverse databases; using mobile health technologies in clinical research; and disseminating information to and mentoring clinical researchers through distributed learning models.


    Core Center for Clinical Research at Northwestern University — This CCCR, led by Leena Sharma, M.D., focuses on lifestyle, behavioral, medical and rehabilitative solutions for individuals who have or are at risk for rheumatic and musculoskeletal conditions. Much of its work involves incorporating mobile and sensor-based technologies into clinical research, with the goal of obtaining rigorous and reproducible measurements for how people feel and function in their daily lives. The investigators expect that their work will improve the efficiency, productivity, and impact of future clinical studies.


    University of Washington Core Center for Clinical Research in Musculoskeletal Diseases — Although electronic health records enable health care systems to amass comprehensive and complex sets of data on large populations, substantial obstacles prevent researchers from transforming routine clinical information into a research-ready resource. The University of Washington CCCR, led by Jeffrey G. Jarvik, M.D., M.P.H., will explore new approaches to adaptive and pragmatic clinical trial designs, develop pipelines and methods for analyzing data for clinical musculoskeletal studies, and provide analysis-ready data sets and services for investigators who wish to conduct such research. The goal is to provide useful research data to health system decision-makers who can apply the results to improve patient care and public health.


  • 02.08.2018 - Hematology-Oncology

    They are among the most challenging prostate cancer patients to treat: about 150,000 men worldwide each year whose cancer is aggressive enough to defy standard hormonal therapy, but has not yet spread to the point where it can be seen on scans.

    These patients enter a tense limbo which often ends too quickly with the cancer metastasizing to their bones, lymph nodes or other organs — sometimes causing intense pain.

    Now, for the first time, researchers have results from two independent clinical trials showing that two different drugs help these patients — giving them about two more years before their cancer metastasizes. That means two additional years before pain and other symptoms spread and they need chemotherapy or other treatments.

  • 02.08.2018 - Infectious Diseases

    Even though nearly half of Chicago’s influenza cases this year involved individuals 65 years and older, the staff at many nursing and rehabilitation centers are not required to receive the flu vaccine. This is a dangerous practice because individuals infected with influenza are generally contagious for 6 to 24 hours before flu-like symptoms appear. Northwestern University's Feinberg School of Medicine professor Michael Ison, MD, MS, notes the dangers of such practices: "[staffers] could become infected and transmit infection to one of the patients” before they are aware of being contagious.

  • The Medical Faculty Council Leadership
    02.07.2018 - General Internal Medicine and Geriatrics
    The Medical Faculty Council (MFC) of the Feinberg School of Medicine (FSM) is pleased to announce that June M. McKoy, MD, MPH, JD, MBA, Associate Professor of Medicine (General Internal Medicine and Geriatrics) and Preventive Medicine, has assumed the Presidency of the MFC, effective immediately.  Dr. McKoy, who previously served as Vice -President, will succeed outgoing President, Dr. James Elliott, PT, PhD who recently relocated to the University of Sydney, Australia. Dr. McKoy is an Associate Professor of Medicine and Preventive Medicine, a member of IPHAM, and a member of the Robert H. Lurie Comprehensive Cancer Center. She brings a strong portfolio of leadership skills and enlightened vision to the position. Dr. McKoy is committed to diversity and inclusiveness and, along with other members of the Council, will continue to strongly advocate for faculty's interests with diplomacy and perseverance.

    The Medical Faculty Council is the representative body of NUFSM faculty, with one member representing every department, center, and institute. Its mission is to foster a culture of academic excellence by promoting transparency, collaboration, communication, and mentorship within the FSM community. The Council also serves as a liaison between the Feinberg faculty and the medical school administration and strives to articulate issues of concern raised by faculty to the medical school administration.

  • 02.07.2018 - Cardiology
    Tammika Glass received her new heart after a 172-day stay at Northwestern Memorial Hospital.  
  • 02.06.2018 - Cardiology
    Featuring:  Micah Eimer, MD
  • 02.06.2018 - Hematology-Oncology

    Treatment with the combination of enzalutamide (Xtandi) and androgen deprivation therapy (ADT) reduced the risk of metastases or death by 71% compared with ADT alone for patients with nonmetastatic castration-resistant prostate cancer (CRPC), according to findings from the phase III PROSPER trial released ahead of the 2018 Genitourinary Cancers Symposium.

    In the double-blind study, the median metastasis-free survival (MFS) was 36.6 months with enzalutamide plus ADT versus 14.7 months with ADT alone (HR, 0.29; 95% Ci, 0.24-0.35; P <.0001). Based on the promising findings, Pfizer and Astellas, the companies developing the antiandrogen agent, have already submitted a supplemental new drug application to the FDA.

    “In the PROSPER trial, treatment with enzalutamide plus ADT delayed the development of metastases compared to standard-of-care ADT alone and, if approved, may provide men with nonmetastatic CRPC an important new treatment option,” lead investigator Maha Hussain, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, said in a statement.

  • 02.06.2018

    Planning for the new Northwestern Medicine Lake Forest Hospital started with research.

    The research was not only about medicine; it also included learning from the people who are around the hospital every day. Patients, nurses and technicians were asked what they liked and disliked about the existing facility built 70 years ago and what they wanted in a new hospital.

    Already operating all but one of its 15 outpatient clinics at the new facility since September 25, the new, nearly 500,000-square-foot, $400 million hospital will begin caring for inpatients March 3.

  • 02.06.2018 - Cardiology
    Featuring:  Micah Eimer, MD
  • 02.05.2018 - Cardiology
    Featuring:  Allen Anderson, MD